NVS logo

NVS
Novartis AG

6,833
Mkt Cap
$299.67B
Volume
4.09M
52W High
$157.57
52W Low
$97.72
PE Ratio
21.71
NVS Fundamentals
Price
$158.20
Prev Close
$157.05
Open
$158.50
50D MA
$140.68
Beta
0.27
Avg. Volume
1.75M
EPS (Annual)
$7.25
P/B
6.50
Rev/Employee
$728,224.22
$293,740.89
Loading...
Loading...
News
all
press releases
INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales
Incyte posts a Q4 EPS miss but a 28% revenue jump, fueled by Jakafi and Opzelura strength, as product sales top estimates.
Zacks·13h ago
News Placeholder
More News
News Placeholder
International ETFs to Watch as Foreign Stock Markets Beat the US
International stocks crushed U.S. markets in 2025, with ETFs such as SPDW and JIVE emerging as top plays on the global shift.
Zacks·15h ago
News Placeholder
Diamond Hill Capital Management Inc. Sells 6,450 Shares of Novartis AG $NVS
Diamond Hill Capital Management Inc. decreased its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 18.8% during the third quarter, according to its most recent filing with the Securities...
MarketBeat·2d ago
News Placeholder
Garland Capital Management Inc. Cuts Position in Novartis AG $NVS
Garland Capital Management Inc. lowered its position in shares of Novartis AG (NYSE:NVS - Free Report) by 72.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund...
MarketBeat·4d ago
News Placeholder
Novartis (NYSE:NVS) Rating Lowered to "Hold" at Wall Street Zen
Wall Street Zen downgraded Novartis from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·4d ago
News Placeholder
Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
INCY heads into Q4 earnings with strong Jakafi sales, rising royalties and multiple new launches contributing to revenues, setting the stage for a potential upside surprise.
Zacks·5d ago
News Placeholder
John G Ullman & Associates Inc. Has $382,000 Stock Position in Novartis AG $NVS
John G Ullman & Associates Inc. cut its position in Novartis AG (NYSE:NVS - Free Report) by 97.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·5d ago
News Placeholder
Envestnet Asset Management Inc. Raises Holdings in Novartis AG $NVS
Envestnet Asset Management Inc. lifted its position in shares of Novartis AG (NYSE:NVS - Free Report) by 4.7% during the third quarter, according to its most recent filing with the Securities and...
MarketBeat·5d ago
News Placeholder
Trump to unveil TrumpRx website where Americans can purchase prescription drugs
President Donald Trump is set to officially unveil a new website called TrumpRx on Thursday evening, which his administration says will allow Americans to purchase prescription drugs at lower...
FOXBusiness.com - Business/Financial·5d ago
News Placeholder
Novartis AG (NYSE:NVS) Plans $4.77 Annual Dividend
Novartis AG (NYSE:NVS) announced an annual dividend on Wednesday, February 4th. Investors of record on Wednesday, March 11th will be paid a dividend of 4.773 per share on Monday, March 16th. This...
MarketBeat·5d ago
<
1
2
...
>

Latest NVS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.